Divi's Laboratories Limited (DIVISLAB)
·Next Day Close·+3.17%·₹8,537
Key EventDivi's Laboratories reappoints directors and declares ₹30 dividend at 36th AGM
Divi's Laboratories Limited (DIVISLAB)
·Next Day Close·-0.52%·₹8,248.5
Key EventDivi's Laboratories reports Q1 FY27 results with 10% constant currency revenue growth and ₹902 crores PAT
ImpactShareholders should note margin pressure from raw material inflation is being addressed through pricing, with double-digit growth expected despite quarterly volatility.Sign up to read impact
Divi's Laboratories Limited (DIVISLAB)
·Next Day Close·+3.3%·₹8,322.85
Key EventAudio recording of Q1 FY27 earnings call made publicly available
ImpactShareholders can now review the full audio of management's discussion on quarterly results and future expectations.Sign up to read impact
Divi's Laboratories Limited (DIVISLAB)
·Next Day Close·+3.3%·₹8,322.85
Key EventBoard approved unaudited Q1 FY2026 financial results and senior management appointments.
ImpactThe company delivered strong YoY growth in profitability and revenue, signaling robust quarterly performance.Sign up to read impact
Divi's Laboratories Limited (DIVISLAB)
·Next Day Close·+3.3%·₹8,322.85
Key EventBoard approves Q1 FY2026 financial results and senior management appointments
ImpactThe company delivered strong YoY growth in revenue and profit, indicating robust quarterly performance.Sign up to read impact
Divi's Laboratories Limited (DIVISLAB)
·Next Day Close·+3.3%·₹8,322.85
Key EventSenior management personnel retire from Divi's Laboratories
ImpactThe retirements are routine compliance updates with no financial impact.Sign up to read impact
Divi's Laboratories Limited (DIVISLAB)
·Next Day Close·+2.34%·₹7,416.35
Key EventDivi's Labs schedules Q1 FY27 earnings call for August 1, 2026
ImpactInvestors can attend the call to hear management discuss quarterly results and future direction.Sign up to read impact
Divi's Laboratories Limited (DIVISLAB)
·Next Day Close·-0.21%·₹6,756.4
Divi's Laboratories submitted a SEBI-mandated certificate from its share transfer agent KFin Technologies for the quarter ended June 30, 2026, confirming dematerialization and rematerialization of securities on both NSE and BSE exchanges. The filing details acceptance/rejection status and registrar verification procedures.
Sign up to read summaryDivis Laboratories Ltd (DIVISLAB)
·Next Day Close·-0.54%·₹6,542.55
Key EventDivi's Laboratories reported Q1 FY27 standalone revenue of ₹3,037 crores, up 10% in constant currency, with profit after tax at ₹891 crores.
ImpactShareholders should note that while revenue and profit grew, margin sustainability is uncertain due to volatile input costs and inventory strategy shifts, making future earnings guidance cautious.Sign up to read impact
Divi's Laboratories Limited (DIVISLAB)
·Next Day Close·-0.27%·₹6,633.05
Divi's Laboratories announced a ₹30 per share dividend for FY2025-26, payable after August 14, 2026, to shareholders on record as of July 24, 2026, subject to AGM approval on August 10, 2026, with mandatory tax withholding documentation required by July 24, 2026, detailing resident and non-resident tax rules, forms like Form 121, and submission via KFintech portals.
Sign up to read summary